Cheng Xu
- Biomedical Engineering top 0.5%
- Molecular Biology top 10%
- Materials Chemistry top 5%
- Immunology top 5%
- Biomaterials top 2%
- Co-authors
- Kanyi PuYuyan JiangJingsheng HuangShasha HeJiaguo HuangChi ZhangYan ZhangMengke Xu
- Topics
- Nanoplatforms for cancer theranostics (38 papers)Advanced biosensing and bioanalysis techniques (7 papers)Photodynamic Therapy Research Studies (7 papers)
- Partner nations
- SingaporeChinaUnited States
In The Last Decade
Cheng Xu
55 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Biomedical Engineering 2.5k
- Molecular Biology 1.2k
- Materials Chemistry 1.2k
- Immunology 498
- Biomaterials 491
Countries citing papers authored by Cheng Xu
This map shows the geographic impact of Cheng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Xu more than expected).
Fields of papers citing papers by Cheng Xu
This network shows the impact of papers produced by Cheng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Xu. The network helps show where Cheng Xu may publish in the future.
Co-authorship network of co-authors of Cheng Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Xu. A scholar is included among the top collaborators of Cheng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Xu. Cheng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 0 | |
| 3 | 7 | |
| 4 | 1 | |
| 5 | Hypoxia-tolerant polymeric photosensitizer prodrug for cancer photo-immunotherapybreakdown → | 19 |
| 6 | 35 | |
| 7 | 20 | |
| 8 | Molecular radio afterglow probes for cancer radiodynamic theranosticsbreakdown → | 131 |
| 9 | 7 | |
| 10 | 2 | |
| 11 | 43 | |
| 12 | 65 | |
| 13 | 9 | |
| 14 | Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancerbreakdown → | 373 |
| 15 | 8 | |
| 16 | 5 | |
| 17 | 47 | |
| 18 | 5 | |
| 19 | 57 | |
| 20 | 69 |
About Cheng Xu
Cheng Xu is a scholar working on Biomedical Engineering, Biomaterials and Immunology, having authored 56 papers that have together received 3.5k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (38 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Photodynamic Therapy Research Studies (7 papers). The work is most often cited by research in Biomedical Engineering (2.5k citations), Biomaterials (491 citations) and Materials Chemistry (1.2k citations). Cheng Xu has collaborated with scholars based in Singapore, China and United States. Frequent co-authors include Kanyi Pu, Yuyan Jiang, Jingsheng Huang, Shasha He, Jiaguo Huang, Chi Zhang, Yan Zhang, Mengke Xu, Xiangliang Yang and Sidney M. Hecht. Their work appears in journals such as Journal of the American Chemical Society, Chemical Society Reviews and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.